NRF2/SLC7A11 axis-mediated metabolic reprogramming drives Benzo[a]pyrene-induced malignant transformation: Evidence...

To elucidate the molecular mechanisms underlying Benzo[a]pyrene (BaP)-induced lung carcinogenesis, we constructed lung organoid and BaP-induced malignant transformation cell model (16HBE-T). Single-cell sequencing analysis confirmed that organoids were primarily composed of basal cells and secretory cells. Following BaP exposure, the lung organoids exhibited G1-phase cell cycle arrest. The expression of CYP1A1 (Log2FC = 10.24) and CYP1B1 (Log2FC = 6.27) were significantly upregulated, while that of SCGB1A1 (Log2FC = -0.26) was downregulated, indicating early-stage lung epithelial injury. Mfuzz soft clustering analysis and FindMarker function were employed to characterize gene expression patterns and identify differentially expressed genes (DEGs). GO, KEGG, GSEA and WikiPathway enrichment analyses revealed that these DEGs were enriched in redox-related metabolic processes (including cysteine/glutamate metabolism and glutathione biosynthesis), NRF2 signaling pathways, and carcinogenesis-associated pathways. Among the DEGs, 9 DEGs were associated with oxidative stress and amino acid metabolism, with SLC7A11 showing the most prominent upregulation (Log2FC = 3.40). The AddModuleScore function indicated that NRF2 exhibited the most significant transcriptional activity. In 16HBE-T cells, the protein expression of SLC7A11 and NRF2 increased by 35.74% and 82.85%, respectively. Knockdown of SLC7A11 significantly inhibited the migration, invasion, and colony-forming abilities of 16HBE-T cells. Meanwhile, intracellular glutamate and cysteine levels decreased, whereas glutamine levels increased. ChIP-PCR verified that NRF2 could directly bind to two specific regions (460-565 bp and 1488-1623 bp) within the SLC7A11 promoter to regulate amino acid metabolism. Collectively, our findings demonstrate that NRF2-regulated SLC7A11-mediated amino acid metabolic reprogramming plays a pivotal role in BaP-induced cellular malignant transformation.